WallStSmart

American Shared Hospital Service (AMS)vsFresenius Medical Care Corporation (FMS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 63778% more annual revenue ($19.43B vs $30.41M). FMS leads profitability with a 4.8% profit margin vs -5.8%. FMS earns a higher WallStSmart Score of 58/100 (C).

AMS

Avoid

35

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 6.7Quality: 4.0
Piotroski: 4/9Altman Z: 0.99

FMS

Buy

58

out of 100

Grade: C

Growth: 4.7Profit: 5.0Value: 9.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMSUndervalued (+41.6%)

Margin of Safety

+41.6%

Fair Value

$3.92

Current Price

$1.47

$2.45 discount

UndervaluedFair: $3.92Overvalued
FMSUndervalued (+68.6%)

Margin of Safety

+68.6%

Fair Value

$76.58

Current Price

$22.35

$54.23 discount

UndervaluedFair: $76.58Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMS2 strengths · Avg: 9.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
19.2%8/10

19.2% revenue growth

FMS3 strengths · Avg: 9.3/10
P/E RatioValuation
11.7x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

PEG RatioValuation
0.738/10

Growing faster than its price suggests

Areas to Watch

AMS4 concerns · Avg: 2.3/10
Market CapQuality
$9.81M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-6.5%2/10

ROE of -6.5% — below average capital efficiency

EPS GrowthGrowth
-38.1%2/10

Earnings declined 38.1%

Altman Z-ScoreHealth
0.992/10

Distress zone — elevated risk

FMS4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.4%4/10

1.4% revenue growth

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Return on EquityProfitability
7.5%3/10

ROE of 7.5% — below average capital efficiency

Profit MarginProfitability
4.8%3/10

4.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : AMS

The strongest argument for AMS centers on Price/Book, Revenue Growth. Revenue growth of 19.2% demonstrates continued momentum.

Bull Case : FMS

The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.

Bear Case : AMS

The primary concerns for AMS are Market Cap, Return on Equity, EPS Growth.

Bear Case : FMS

The primary concerns for FMS are Revenue Growth, Altman Z-Score, Return on Equity. Thin 4.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

AMS profiles as a growth stock while FMS is a value play — different risk/reward profiles.

FMS carries more volatility with a beta of 0.83 — expect wider price swings.

AMS is growing revenue faster at 19.2% — sustainability is the question.

FMS generates stronger free cash flow (620M), providing more financial flexibility.

Bottom Line

FMS scores higher overall (58/100 vs 35/100). AMS offers better value entry with a 41.6% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American Shared Hospital Service

HEALTHCARE · MEDICAL CARE FACILITIES · USA

American Shared Hospital Services rents radiosurgery and radiation therapy equipment to healthcare providers. The company is headquartered in San Francisco, California.

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

Want to dig deeper into these stocks?